TRELAVUE


Film-coated tablets
scheduling status
S4
registration number
49/20.2.8/0097
What TRELAVUE contains
Dolutegravir/Abacavir/Lamivudine.
other ingredients
Tablet Core: D-Mannitol, magnesium stearate, Microcrystalline cellulose, Povidone K29/32, Sodium starch glycolate. Tablet coating: Opadry II Purple 85F90057 containing: Polyvinyl alcohol – Part hydrolysed, Titanium oxide, Macrogol/PEG, talc, Iron oxide black, Iron oxide red.
Therapeutic classification
J05AR13.
© 2026 SAHPRA. ALL RIGHTS RESERVED